We performed immunoblot analysis of tumor protein extracts collected at endpoint and found that p53−/− AMPK β1−/− tumors had large reductions in total AMPK α expression and AMPK activating phosphorylation at Thr172 (Fig. 3A–C). This evidence concerns the gene TP53 and neoplasm.